Surgery in renal cell carcinoma—when, whom and how?

被引：0

作者：

Sebastian Lenart

Ingrid Berger

Nikolaus Hartig

Stephan Madersbacher

Anton Ponholzer

机构：

[1] St. John of God Hospital Vienna—Krankenhaus der Barmherzigen Brüder Wien,Department of Urology and Andrology

[2] Paracelsus Medical University Salzburg,Department of Urology

[3] St. John of God Hospital Vienna—Krankenhaus der Barmherzigen Brüder Wien,Department of Surgery

[4] Kaiser-Franz-Josef-I. Hospital Vienna,Department of Urology and Andrology

[5] Sigmund Freud Private University,undefined

来源：

memo - Magazine of European Medical Oncology | 2019年 / 12卷

关键词：

Treatment algorithm for renal cell carcinoma; Radical nephrectomy; Partial nephrectomy; Robot assisted nephrectomy; Robot assisted partial nephrectomy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Surgical resection of RCC should be the aim for cure of localized or locally advanced RCC, either by partial or radical nephrectomy, depending on tumor size and patient’s performance status. In cT1 stages partial nephrectomy is recommended. In metastatic stage, immediate CN can be performed in patients with good performance status, who do not need systemic therapy because of oligometatastic disease with feasibility of complete resection.

引用

页码：347 / 351

页数：4

共 50 条

[1] Surgery in renal cell carcinoma-when, whom and how?
Lenart, Sebastian
Berger, Ingrid
Hartig, Nikolaus
Madersbacher, Stephan
Ponholzer, Anton
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (04) : 347 - 351
[2] Prophylactic Surgery: For Whom, When and How?
Mau, Christine
Untch, Michael
BREAST CARE, 2017, 12 (06) : 379 - 384
[3] Metastasectomy in patients with renal cell carcinoma: when and how?
Omid, Sara
Abufaraj, Mohammad
Remzi, Mesut
CURRENT OPINION IN UROLOGY, 2020, 30 (04) : 602 - 609
[4] PARATHYROIDECTOMY IN SECONDARY (RENAL) HYPERPARATHYROIDISM - WHOM, WHEN, HOW
RITZ, E
SZABO, A
REICHEL, H
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (01): : 7 - 9
[5] Surveillance for renal cell carcinoma: Why and how? When and how often?
Klatte, Tobias
Lam, John S.
Shuch, Brian
Belldegrun, Arie S.
Pantuck, Allan J.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) : 550 - 554
[6] Metabolic and Bariatric Surgery in Adolescents: For Whom, When, and How?
Janson, Annika
Jarvholm, Kajsa
Sjogren, Lovisa
Dahlgren, Jovanna
Beamish, Andrew J.
Gronowitz, Eva
Olbers, Torsten
HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (06): : 609 - 619
[7] RENAL BIOPSIES FOR SMALL RENAL MASSES. FOR WHOM, WHEN AND HOW
Stakhovskyi, Oleksandr
Sanchez-Salas, Rafael
Barret, Eric
Yap, Stanley A.
Finelli, Antonio
Rozet, Francois
Galiano, Marc
Lenoir, Stephane
Strauss, Christiane
Validire, Pierre
Cathelineau, Xavier
ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (01): : 4 - 15
[8] Renal Replacement Therapy in the Age at whom, when, how, how long?
Hoffmann, U.
Sieber, C.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (31-32) : 1568 - 1571
[9] Oligo Metastatic renal cell carcinoma: SBRT, if, when and how?
Marvaso, G.
Corrao, G.
Oneta, O.
Gugliandolo, S. G.
Pepa, M.
Cecconi, A.
Gandini, S.
Piperno, G.
Rocca, M. Cossu
Verri, E.
Aurilio, G.
Corso, F.
Cullura, D.
Rondi, E.
Vigorito, S.
Nole, F.
Orecchia, R.
Jereczek-Fossa, B. A.
RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S641 - S642
[10] How Targeted Therapy Influence Renal Surgery for Renal Cell Carcinoma
Greco, Francesco
Marchioni, Michele
Esperto, Francesco
Papalia, Rocco
Schips, Luigi
Scarpa, Roberto M.
CURRENT DRUG TARGETS, 2020, 21 (15) : 1550 - 1557

← 1 2 3 4 5 →